BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Piplani S, Singh PK, Winkler DA, Petrovsky N. Computationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapies. Mol Biomed 2021;2:28. [PMID: 34766004 DOI: 10.1186/s43556-021-00050-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Piplani S, Singh P, Winkler DA, Petrovsky N. Potential COVID-19 Therapies from Computational Repurposing of Drugs and Natural Products against the SARS-CoV-2 Helicase. IJMS 2022;23:7704. [DOI: 10.3390/ijms23147704] [Reference Citation Analysis]
2 Denel-bobrowska M, Olejniczak AB. Non-nucleoside structured compounds with antiviral activity—past 10 years (2010–2020). European Journal of Medicinal Chemistry 2022;231:114136. [DOI: 10.1016/j.ejmech.2022.114136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Piplani S, Singh P, Winkler DA, Petrovsky N. Rational Repurposing of Drugs, Clinical Trial Candidates, and Natural Products for SARS-CoV-2 Therapy. Frontiers of COVID-19 2022. [DOI: 10.1007/978-3-031-08045-6_23] [Reference Citation Analysis]